SS-31
Elamipretide / Szeto-Schiller peptide
Mechanism of Action
Mitochondria-targeted antioxidant peptide. Concentrates in the inner mitochondrial membrane, reduces reactive oxygen species, and protects cardiolipin from oxidative damage.
Key Benefits
- Mitochondrial protection and function improvement
- Cardiac protection and recovery
- Renal protection in ischemia-reperfusion
- Reduced oxidative stress
Dosing Protocol
Mitochondria-targeted antioxidant with promising cardiac and renal protection data.
Ideal Candidates
Heart failure, renal disease, mitochondrial dysfunction, aging.
Side Effects & Safety
Injection site reactions. Generally well-tolerated in trials.
Regulatory Status
Gray AreaNot on the 503A bulks list. Significant clinical trial data for cardiac indications.
Frequently asked
What is SS-31?+
SS-31 (Elamipretide / Szeto-Schiller peptide) is a peptide studied for mitochondrial protection and cardiac recovery. Mitochondria-targeted antioxidant peptide. Concentrates in the inner mitochondrial membrane, reduces reactive oxygen species, and protects cardiolipin from oxidative damage.
What is the dosing protocol for SS-31?+
Literature commonly references 0.05 mg/kg/day (low) to 0.25 mg/kg/day (maintenance) via SubQ daily, on a 4–12 weeks cycle. Educational reference only — a licensed Stackhaus Health provider sets any personalized protocol.
What is the regulatory status of SS-31?+
Not on the 503A bulks list. Significant clinical trial data for cardiac indications.
Where can I access SS-31?+
Research-grade SS-31 is available through Stackhaus Research. For a personalized, provider-reviewed protocol, consult a licensed clinician through Stackhaus Health.